Heart failure with preserved ejection fraction (HFpEF) has emerged as one of the most significant clinical...

Heart failure impacts men and women differently, exhibiting distinct epidemiological patterns, clinical presentations, responses to...

Cardiac implantable electronic devices (CIEDs) have transformed the management of bradyarrhythmias, malignant ventricular arrhythmias...

Hypertension is common and remains one of the most modifiable risk factors encountered in clinical practice....

Cardiovascular diseases (CVDs) are the leading global killer, causing about 17.9 million deaths in 2019.1 In...

Nicotine is toxic to the heart and blood vessels, regardless of whether it is consumed via...

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, placing a substantial burden...

In this issue, new ESTRO guidelines on re-irradiation of spinal metastases, and highlightsfrom the American Society...

New data presented at ESMO 2025 suggests antibody-drug conjugates (ADCs) dramatically improve outcomes for patients with...

Stereotactic body radiotherapy (SBRT) is an established treatment for previously unirradiated spinal metastases, however...

BTK. Also presented at the ASH Annual Meeting were the results from the first randomised phase...

New research presented at the 67th American Society of Hematology (ASH) Annual Meeting in December 2025...